Viemed Healthcare (NASDAQ:VMD) Upgraded at Zacks Research

Zacks Research upgraded shares of Viemed Healthcare (NASDAQ:VMD) to a hold rating in a report released on Thursday morning,Zacks.com reports.

Several other research firms have also commented on VMD. Weiss Ratings restated a “hold (c)” rating on shares of Viemed Healthcare in a research report on Monday, December 29th. Wall Street Zen cut Viemed Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Two equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, Viemed Healthcare presently has an average rating of “Hold”.

Viemed Healthcare Stock Up 0.1%

Viemed Healthcare stock opened at $7.24 on Thursday. The business’s 50-day moving average price is $6.94 and its 200 day moving average price is $6.85. The company has a quick ratio of 1.01, a current ratio of 1.13 and a debt-to-equity ratio of 0.14. The firm has a market cap of $275.26 million, a price-to-earnings ratio of 21.94 and a beta of 1.25. Viemed Healthcare has a 52 week low of $5.93 and a 52 week high of $8.61.

Viemed Healthcare (NASDAQ:VMD) last released its quarterly earnings data on Wednesday, November 5th. The company reported $0.09 EPS for the quarter, hitting the consensus estimate of $0.09. The business had revenue of $71.91 million for the quarter, compared to analyst estimates of $72.00 million. Viemed Healthcare had a return on equity of 9.95% and a net margin of 5.34%.

Institutional Trading of Viemed Healthcare

A number of institutional investors and hedge funds have recently modified their holdings of VMD. Quarry LP purchased a new position in Viemed Healthcare in the 3rd quarter valued at about $48,000. AQR Capital Management LLC purchased a new stake in Viemed Healthcare during the 1st quarter worth approximately $90,000. SG Americas Securities LLC acquired a new position in shares of Viemed Healthcare during the fourth quarter valued at approximately $101,000. Cardinal Point Capital Management ULC purchased a new position in shares of Viemed Healthcare in the second quarter valued at approximately $128,000. Finally, Intech Investment Management LLC lifted its position in shares of Viemed Healthcare by 14.4% in the second quarter. Intech Investment Management LLC now owns 18,612 shares of the company’s stock valued at $129,000 after acquiring an additional 2,349 shares in the last quarter. Hedge funds and other institutional investors own 74.24% of the company’s stock.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.